AGILE THERAPEUTICS INC - COM (AGRX)

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COM
Total 13F shares
31,750,559
Share change
-2,610,866
Total reported value
$30,507,855
Put/Call ratio
8.5%
Price per share
$0.96
Number of holders
47
Value change
-$2,822,129
Number of buys
11
Number of sells
37

Institutional Holders of AGILE THERAPEUTICS INC - COM (AGRX) as of Q3 2021

As of 30 Sep 2021, AGILE THERAPEUTICS INC - COM (AGRX) was held by 47 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,750,559 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, INVESTOR AB, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, ROYAL BANK OF CANADA, NEEDHAM INVESTMENT MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, GSA CAPITAL PARTNERS LLP, and MORGAN STANLEY. This page lists 47 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.